Skip to content

13F-HR filed by First Light Asset Management, LLC

First Light Asset Management, LLC filed this 13F-HR for the quarter ended 2014-12-31, filed 2015-02-17, with 66 holding rows worth $176,464,000.

Accession
0001387131-15-000585
Filed
2015-02-17
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2014

A holdings report, 66 entries on the cover page, a total value of $176,464,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $176,464,000 with VALUE read as thousands by filing date, 13F file number 028-16064. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ATRICURE INC04963C209COM636,170$12,698,000thousands by filing date
NEOGENOMICS INC64049M209COM NEW2,683,090$11,188,000thousands by filing date
SPECTRANETICS CORP84760C107COM312,258$10,798,000thousands by filing date
AKORN INC009728106COM232,692$8,423,000thousands by filing date
HARVARD BIOSCIENCE INC416906105COM1,412,719$8,010,000thousands by filing date
RTI BIOLOGICS INC74975N105COM1,413,810$7,352,000thousands by filing date
NXSTAGE MEDICAL INC67072V103COMMON STOCK373,164$6,691,000thousands by filing date
IGI LABORATORIES INC449575109COM734,460$6,463,000thousands by filing date
Enzo Biochem Inc294100102Common Stock1,213,901$5,390,000thousands by filing date
ARRAY BIOPHARMA INC COM04269X105Stock1,129,560$5,343,000thousands by filing date
LIGAND PHARMACEUTICALS INC53220K504COM NEW81,952$4,361,000thousands by filing date
ALKERMES PLCG01767105SHS70,861$4,150,000thousands by filing date
QUIDEL CORP74838J101COM143,092$4,138,000thousands by filing date
OMNICELL COM COM68213N109Stock120,485$3,990,000thousands by filing date
STREAMLINE HEALTH SOLUTIONS86323X106COM903,732$3,913,000thousands by filing date
ENDOLOGIX INC29266S106COM250,369$3,828,000thousands by filing date
VERACYTE INC COM92337F107Stock393,926$3,805,000thousands by filing date
OXFORD IMMUNOTEC GLOBAL PLCG6855A103ORD SHS273,473$3,725,000thousands by filing date
NOVADAQ TECHNOLOGIES INC COMMON66987G102COM222,899$3,705,000thousands by filing date
ANGIODYNAMICS INC03475V101COM194,512$3,698,000thousands by filing date
BIO-TECHNE CORP09073M104COM39,243$3,626,000thousands by filing date
VANDA PHARMACEUTICALS INC921659108COM229,818$3,291,000thousands by filing date
CELLDEX THERAPEUTICS INC NEW15117B103COM153,617$2,804,000thousands by filing date
STAAR SURGICAL CO COM PAR $0.01852312305Stock306,381$2,791,000thousands by filing date
STANDARD BIOTOOLS INC34385P108COM80,613$2,719,000thousands by filing date
TEARLAB CORP878193101COM953,211$2,526,000thousands by filing date
HEALTHSTREAM INC42222N103COM82,445$2,430,000thousands by filing date
CEPHEID15670R107COM44,758$2,423,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM17,591$2,090,000thousands by filing date
ALIGN TECHNOLOGY INC COM016255101Stock36,739$2,054,000thousands by filing date
LEMAITRE VASCULAR INC525558201COM263,146$2,013,000thousands by filing date
SALIX PHARMACEUTICALS INC795435106COM17,421$2,002,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM22,062$1,994,000thousands by filing date
LANNETT COMPANY INCORPORATED516012101COM45,765$1,962,000thousands by filing date
ISIS PHARMACEUTICALS INC464330109COM29,505$1,822,000thousands by filing date
SUNOPTA INC8676EP108COM132,984$1,576,000thousands by filing date
BLUEBIRD BIO INC09609G100COM16,008$1,468,000thousands by filing date
CYTOKINETICS INC23282W605COM NEW179,189$1,435,000thousands by filing date
SPECTRUM PHARMACEUTICALS INC84763A108COM188,172$1,304,000thousands by filing date
SAGENT PHARMACEUTICALS INC786692103COM43,081$1,082,000thousands by filing date
ARATANA THERAPEUTICS INC03874P101COM58,065$1,035,000thousands by filing date
ENDO INTL PLCG30401106SHS8,161$589,000thousands by filing date
NOVARTIS AG SPONSORED ADR66987V109ADR6,070$562,000thousands by filing date
MYLAN INC628530107COM9,775$551,000thousands by filing date
ACTAVIS PLCG0083B108SHS2,035$524,000thousands by filing date
Elevance Health, Inc.036752103COM4,095$515,000thousands by filing date
HUMANA INC COM444859102Stock3,540$508,000thousands by filing date
UNITED THERAPEUTICS CORP DEL COM91307C102Stock3,820$495,000thousands by filing date
Bristol-Myers Squibb Company110122108COM8,290$489,000thousands by filing date
CELGENE CORP151020104COM4,280$479,000thousands by filing date
AETNA INC NEW00817Y108COM5,215$463,000thousands by filing date
CAREFUSION CORP14170T101COM7,730$459,000thousands by filing date
STERIS CORP859152100COMMON STOCK6,330$411,000thousands by filing date
ASTRAZENECA PLC SPONSORED ADR046353108ADR5,680$400,000thousands by filing date
Johnson & Johnson478160104COM3,820$399,000thousands by filing date
ST JUDE MED INC790849103COM6,055$394,000thousands by filing date
BECTON DICKINSON & CO075887109COM2,795$389,000thousands by filing date
Eli Lilly and Company532457108COM5,495$379,000thousands by filing date
Merck & Co.,Inc.58933Y105COM6,610$375,000thousands by filing date
Amgen Inc.031162100COM2,330$371,000thousands by filing date
COMMUNITY HEALTH SYSTEMS INC203668108COMMON STOCK6,145$331,000thousands by filing date
Pfizer Inc.717081103COM10,520$328,000thousands by filing date
MYRIAD GENETICS INC62855J104COM7,820$266,000thousands by filing date
SANOFI SA SPONSORED ADR80105N105ADR5,680$259,000thousands by filing date
AGILENT TECHNOLOGIES INC COM00846U101Stock5,120$210,000thousands by filing date
BIO RAD LABS INC090572207CL A1,675$202,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001387131-15-000585this filing2015-02-17acceptance time not in the bulk data set